Company profile
AETHLON MEDICAL INC
NASDAQ:AEMDMedical/Dental Instruments
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04453046 | — | terminated | 2020-10-22 | 2022-11-14 | Aethlon Medical Inc. | Hemopurifier Plus Pembrolizumab in Head and Neck Cancer |
FDA applications (0)
No records yet.